Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Bachy

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Cell Death Discovery|June 19, 2024
Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphomaAdrien Krug, Rana Mhaidly, Marie Tosolini, et al.
Blood Advances|April 17, 2023
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA groupYassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, et al.
Blood Advances|January 28, 2025
Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA studyXavier Phina-Ziebin, Emmanuel Bachy, François-Xavier Gros, et al.
Blood|July 12, 2019
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemiaPhilipp B Staber, Marco Herling, Mar Bellido, et al.
Scientific Reports|November 5, 2020
Description of neurotoxicity in a series of patients treated with CAR T-cell therapyCatherine Belin, Perrine Devic, Xavier Ayrignac, et al.
Blood Advances|April 19, 2022
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphomaEstelle Bourbon, Pierre Sesques, Morgane Gossez, et al.
Bone Marrow Transplantation|April 17, 2021
Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMTToby A Eyre, Sophie Caillard, Herve Finel, et al.
American Journal of Hematology|August 16, 2023
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCLKai Rejeski, Yucai Wang, Omar Albanyan, et al.
Hemasphere|December 10, 2025
Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysisJean Galtier, Pierre Sesques, Vivien Dupont, et al.
Journal of Hematology & Oncology|July 31, 2023
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myelomaKai Rejeski, Doris K Hansen, Radhika Bansal, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Cell Death Discovery|June 19, 2024
Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphomaAdrien Krug, Rana Mhaidly, Marie Tosolini, et al.
Blood Advances|April 17, 2023
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA groupYassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, et al.
Blood Advances|January 28, 2025
Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA studyXavier Phina-Ziebin, Emmanuel Bachy, François-Xavier Gros, et al.
Blood|July 12, 2019
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemiaPhilipp B Staber, Marco Herling, Mar Bellido, et al.
Scientific Reports|November 5, 2020
Description of neurotoxicity in a series of patients treated with CAR T-cell therapyCatherine Belin, Perrine Devic, Xavier Ayrignac, et al.
Blood Advances|April 19, 2022
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphomaEstelle Bourbon, Pierre Sesques, Morgane Gossez, et al.
Bone Marrow Transplantation|April 17, 2021
Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMTToby A Eyre, Sophie Caillard, Herve Finel, et al.
American Journal of Hematology|August 16, 2023
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCLKai Rejeski, Yucai Wang, Omar Albanyan, et al.
Hemasphere|December 10, 2025
Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysisJean Galtier, Pierre Sesques, Vivien Dupont, et al.
Journal of Hematology & Oncology|July 31, 2023
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myelomaKai Rejeski, Doris K Hansen, Radhika Bansal, et al.
Pageof 18